Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2023 Filed Jan 19, 2023 21:46 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 14 | $357.74 | $5,008.36 |
DisclosureSEC source: 0000059478-23-000014 · wf-form4_167416476756500.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,599 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:49 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 6 | $357.74 | $2,146.44 |
DisclosureSEC source: 0000059478-23-000016 · wf-form4_167416492681747.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,450 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:07 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 32 | $357.78 | $11,448.96 |
DisclosureSEC source: 0000059478-22-000279 · wf-form4_167157403107262.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,706 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:09 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 28 | $357.78 | $10,017.84 |
DisclosureSEC source: 0000059478-22-000281 · wf-form4_167157415592391.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,581 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:11 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 28 | $357.78 | $10,017.84 |
DisclosureSEC source: 0000059478-22-000283 · wf-form4_167157425145374.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:12 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 27 | $357.78 | $9,660.06 |
DisclosureSEC source: 0000059478-22-000285 · wf-form4_167157436015758.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:14 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 39 | $357.78 | $13,953.42 |
DisclosureSEC source: 0000059478-22-000287 · wf-form4_167157444176418.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,698 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 19, 2022 Filed Dec 20, 2022 22:15 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 28 | $357.78 | $10,017.84 |
DisclosureSEC source: 0000059478-22-000289 · wf-form4_167157454149342.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,895 | $374.56 | $2,208,037.10 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,948,810 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.04 to $374.965, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,930 | $373.41 | $6,321,746.65 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,954,705 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.00 to $373.985, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 18,464 | $372.46 | $6,877,082.98 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,971,635 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.00 to $372.99, inclusive. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 17:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,800 | $371.45 | $2,897,325.60 |
DisclosureSEC source: 0001209191-22-059567 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,990,099 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.00 to $371.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 500 | $375.18 | $187,587.50 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,997,899 Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,162 | $374.32 | $1,557,936.49 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,998,399 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.005 to $374.785, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,184 | $373.39 | $2,309,037.58 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,002,561 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.00 to $373.935, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 5,759 | $372.32 | $2,144,196.64 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,008,745 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $372.00 to $372.95, inclusive. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 16:29 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 144,306 | $371.34 | $53,586,734.35 |
DisclosureSEC source: 0001209191-22-059288 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,014,504 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $371.00 to $371.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:08 UTC |
Baicker KatherineDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000252 · wf-form4_166915488271701.xml · nonDerivative · entry 1 Baicker Katherine · CIK 0001537067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,095 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:15 UTC |
Kaelin William G JrDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000256 · wf-form4_166915531957681.xml · nonDerivative · entry 1 Kaelin William G Jr · CIK 0001551715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,470 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:11 UTC |
JACKSON JAMEREDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000254 · wf-form4_166915509571116.xml · nonDerivative · entry 1 JACKSON JAMERE · CIK 0001601813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,370 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:20 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000258 · wf-form4_166915558907692.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,402 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:27 UTC |
Runge Marschall SDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000261 · wf-form4_166915605731417.xml · nonDerivative · entry 1 Runge Marschall S · CIK 0001586197 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,087 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:31 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000265 · wf-form4_166915626670966.xml · nonDerivative · entry 2 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,362 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:31 UTC |
Fyrwald J ErikDirector
|
GrantCommon Stock | 27 | $361.17 | $9,751.59 |
DisclosureSEC source: 0000059478-22-000265 · wf-form4_166915626670966.xml · nonDerivative · entry 1 Fyrwald J Erik · CIK 0001343564 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,864 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:33 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 332 | $361.17 | $119,908.44 |
DisclosureSEC source: 0000059478-22-000267 · wf-form4_166915637324950.xml · nonDerivative · entry 2 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:33 UTC |
Hedley Mary LynneDirector
|
GrantCommon Stock | 27 | $361.17 | $9,751.59 |
DisclosureSEC source: 0000059478-22-000267 · wf-form4_166915637324950.xml · nonDerivative · entry 1 Hedley Mary Lynne · CIK 0001340823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:29 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000263 · wf-form4_166915614214464.xml · nonDerivative · entry 2 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,531 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:29 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 31 | $361.17 | $11,196.27 |
DisclosureSEC source: 0000059478-22-000263 · wf-form4_166915614214464.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,033 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:34 UTC |
Walker KarenDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000268 · wf-form4_166915646583226.xml · nonDerivative · entry 1 Walker Karen · CIK 0001642519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,514 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:36 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000270 · wf-form4_166915656781582.xml · nonDerivative · entry 2 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,922 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:36 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 27 | $361.17 | $9,751.59 |
DisclosureSEC source: 0000059478-22-000270 · wf-form4_166915656781582.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:38 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000272 · wf-form4_166915669731679.xml · nonDerivative · entry 2 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,622 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:38 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 39 | $361.17 | $14,085.63 |
DisclosureSEC source: 0000059478-22-000272 · wf-form4_166915669731679.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,124 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:40 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 498 | $361.17 | $179,862.66 |
DisclosureSEC source: 0000059478-22-000274 · wf-form4_166915683557821.xml · nonDerivative · entry 2 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,554 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:40 UTC |
Sulzberger GabrielleDirector
|
GrantCommon Stock | 27 | $361.17 | $9,751.59 |
DisclosureSEC source: 0000059478-22-000274 · wf-form4_166915683557821.xml · nonDerivative · entry 1 Sulzberger Gabrielle · CIK 0001262388 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,056 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,787 | $366.42 | $1,021,220.90 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,158,810 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $366.04 to $366.90, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,187 | $365.39 | $3,356,847.12 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,161,597 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.01 to $365.99, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 19,415 | $364.47 | $7,076,223.88 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,170,784 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $364.01 to $365.00, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 17,916 | $363.54 | $6,513,164.72 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,190,199 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.00 to $363.99, inclusive. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 18:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,280 | $362.30 | $5,173,586.88 |
DisclosureSEC source: 0001209191-22-056062 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,208,115 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 19:34 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 686 | $365.20 | $250,527.20 |
DisclosureSEC source: 0001209191-22-055915 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,222,395 Read SEC document |
| November 04, 2022 Filed Nov 7, 2022 19:34 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 650 | $362.26 | $235,469.00 |
DisclosureSEC source: 0001209191-22-055915 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,223,081 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.02 to $362.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 16:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 133,948 | $362.08 | $48,499,891.84 |
DisclosureSEC source: 0001209191-22-055740 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,223,731 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.645, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| November 02, 2022 Filed Nov 3, 2022 16:16 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,131 | $362.07 | $2,219,851.17 |
DisclosureSEC source: 0001209191-22-055450 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,357,679 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.00 to $362.25, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,300 | $342.15 | $786,951.90 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,363,810 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.06 to $342.24, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 28,902 | $341.33 | $9,865,177.46 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,366,110 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.04 to $342.0255, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 16,568 | $340.80 | $5,646,374.40 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,395,012 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.035 to $341.03, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,465 | $339.37 | $2,533,389.59 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,411,580 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.035 to $340.02, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,571 | $338.49 | $14,071,326.22 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,419,045 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.02 to $339.01, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 20:10 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 14,987 | $337.30 | $5,055,085.13 |
DisclosureSEC source: 0001209191-22-054393 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,460,616 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.00 to $337.96, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.